Related by context. All words. (Click for frequent words.) 79 Diamyd R 74 Diamyd r 72 YONDELIS 71 IMA# 71 Archexin 70 SNT MC# 70 Alzhemed TM 70 OvaRex ® MAb 69 ONCONASE R 69 MAGE A3 ASCI 69 Pimavanserin 69 NP2 Enkephalin 69 acyclovir Lauriad R 69 TBC# 69 PDE4 inhibitor 68 MKC# MT 68 phase IIa clinical 68 RhuDex ® 68 Fodosine 68 TRO# 68 Cetrorelix 68 torezolid phosphate 68 Mipomersen 68 JAK inhibitor 68 mertansine 68 Civacir 68 Phase IIb clinical trials 68 methylnaltrexone 68 Aflibercept 68 R#/MEM # 68 Allovectin 7 68 volociximab 68 forodesine 68 elotuzumab 67 Amrubicin 67 tramiprosate Alzhemed TM 67 otelixizumab 67 CEQ# 67 QNEXA ® 67 phase IIb trial 67 Allovectin 7 R 67 midstage clinical 67 glucokinase activator 67 Virulizin ® 67 Aryplase 67 CR# vcMMAE 67 Nanobody 67 Plicera 67 Behcet uveitis 67 antibody MAb 67 Corlux 67 AEG# 67 NV1FGF 67 ATL# [001] 67 BioNumerik 67 Phenoptin 67 teplizumab 67 Dapagliflozin 67 Arranon 67 Oglemilast 67 Canvaxin 67 GW# [003] 67 LymphoStat B belimumab 66 Aplidin 66 Phase 2a clinical trials 66 MEK inhibitor 66 Alocrest 66 Velcade bortezomib 66 GSK# [001] 66 HuLuc# 66 GRN# 66 ELACYT 66 Allovectin 7 ® 66 Exherin TM 66 phase IIb clinical 66 Panzem 66 Traficet EN 66 ThGRF 66 cathepsin K inhibitor 66 Aurexis 66 RhuDex 66 HQK 66 Panzem R 66 Onconase 66 receptor tyrosine kinase inhibitor 66 phase IIa 66 INCB# [001] 66 PSMA ADC 66 TACI Ig 66 GRNVAC1 66 Proellex TM 66 HuMax CD4 66 ospemifene 66 Safinamide 66 Amigal 66 UVIDEM 66 YONDELIS R 66 Balaglitazone 66 Phase #b/#a 66 reslizumab 66 ACOMPLIA R 66 alvespimycin 66 tramiprosate ALZHEMED TM 66 Genz # 66 Insegia 66 huC# DM4 66 NeuVax 66 Fibrillex TM 65 immunotherapeutic vaccine 65 HCD# [002] 65 Ataluren 65 anticancer compound 65 Vernakalant 65 BRAF inhibitor 65 synthetic retinoid 65 tanespimycin 65 DEB# 65 GLPG# 65 GALNS 65 SinuNase TM 65 oral methylnaltrexone 65 Icatibant 65 Sudhir Agrawal D.Phil 65 CDP# 65 ZOLINZA 65 oral ridaforolimus 65 ocrelizumab 65 BZL# 65 liposomal formulation 65 Daclizumab 65 pomalidomide 65 Jevtana 65 Ocrelizumab 65 Intravenous CP 65 pafuramidine 65 RhuDex R 65 BAY #-# 65 phase III isavuconazole 65 Nexavar sorafenib 65 Aviptadil 65 talactoferrin 65 Tasimelteon 65 IIa trial 65 IL# PE#QQR 65 FOLOTYN ® 65 JAK inhibitors 65 EndoTAG TM -1 65 OHR/AVR# 65 elacytarabine 65 dirucotide MBP# 65 Dacogen injection 65 RELOVAIR ™ 65 compound INCB# 65 Panzem R NCD 65 Phase Ib study 65 bardoxolone 65 CTAP# Capsules 65 StaphVAX R 65 DermaVir Patch 65 darapladib 65 Fibrillex 65 canakinumab 65 HuMax TAC 65 Raptiva R 65 lintuzumab SGN 65 Asentar 65 Fx #A 65 Phase IIb trials 65 Ceflatonin 65 ixabepilone 65 Benlysta belimumab 65 Canvaxin TM 65 efalizumab 65 maribavir 65 oral talactoferrin 65 nalbuphine ER 65 EOquin TM 65 Exelixis XL# 65 PHX# 65 proteasome inhibitor 65 RSD# oral 65 Temsirolimus 65 Zemplar Capsules 65 daclizumab 65 placebo controlled Phase 65 dose cohort 64 Phase IIa trial 64 davalintide 64 TEMODAL 64 Lu AA# 64 tolevamer 64 vidofludimus 64 SinuNase ™ 64 Prodarsan 64 indibulin 64 MAA submission 64 Diamyd 64 Phase 2a trial 64 Zolinza 64 Pertuzumab 64 Veronate 64 aflibercept 64 alemtuzumab Campath 64 trastuzumab DM1 T DM1 64 PD LID 64 liprotamase 64 MYDICAR 64 TransVax ™ 64 EndoTAG 64 FRDA 64 Theratope 64 Triolex 64 HuMax EGFr 64 ALN PCS 64 PROSTVAC TM 64 SAR# [004] 64 Orphan Status 64 Olaparib 64 Tarceva TM 64 vosaroxin 64 Lupuzor 64 midstage trials 64 ALN RSV# 64 PI3K/Akt pathway inhibitor 64 GSK# [002] 64 registrational trial 64 eprotirome 64 ELND# 64 Pirfenidone 64 baminercept 64 Cancidas 64 iniparib 64 MYDICAR ® 64 Proxinium TM 64 relapsed MM 64 rilonacept 64 SNT-MC#/idebenone 64 UPLYSO 64 Symadex 64 Bezielle 64 GAMMAGARD 64 G#DT 64 targeted radiotherapeutic 64 multicenter Phase II 64 ponatinib 64 PrevOnco 64 OncoVEX GM CSF 64 phase Ib 64 Sym# 64 lumiliximab 64 CCX# 64 senicapoc 64 ALN TTR 64 octreotide implant 64 BLA filing 64 riociguat 64 Phase Ib II 64 teriflunomide 64 StemEx R 64 Saxagliptin 64 Troxatyl 64 TransVax TM 64 cannabinor 64 Crizotinib 64 6R BH4 64 Torisel 64 Vandetanib 64 rolapitant 64 bardoxolone methyl 64 Neo Bladder Augment 64 Cogane 64 midstage studies 64 Prosaptide 64 MORAb 64 Phase IIIb clinical 64 INCB# [003] 64 Cloretazine ® 64 SEBIVO 64 PF # [002] 64 vemurafenib 64 Catena ® 64 Cethrin 64 Vidaza azacitidine 64 sorafenib tablets 64 ATL/TV# 64 BiovaxID TM 64 metaglidasen 64 orally administered inhibitor 64 Personalized Immunotherapy 64 anti CD3 antibody 64 Dr. McHutchison 64 Memryte 64 Rasagiline 64 MKC# 64 CIMZIA ™ 63 RhuDex TM 63 ASONEP 63 Golimumab 63 PLK1 SNALP 63 Zerenex 63 albinterferon alfa 2b 63 CBLC# 63 rPA anthrax vaccine 63 Campath ® 63 Viramidine 63 Actimmune ® 63 sunitinib malate 63 Ceflatonin R 63 Mepact 63 eritoran 63 lorvotuzumab mertansine 63 CIMZIA TM 63 non nucleoside HCV 63 teduglutide 63 Hedgehog antagonist 63 Laquinimod 63 Uplyso 63 Raptiva ® 63 Spiegelmer ® 63 ACTEMRA TM 63 Oral NKTR 63 thymalfasin 63 Azedra 63 refractory gout 63 Shigamabs ® 63 pradefovir 63 BLA submission 63 REGN# 63 Muraglitazar 63 Onrigin 63 PREOS R 63 relapsing remitting MS RRMS 63 antisense drug 63 dosing cohort 63 Cethromycin 63 orBec 63 selective modulator 63 novel VDA molecule 63 romiplostim 63 IRX 2 63 STRIDE PD 63 DCVax R 63 Guanilib 63 Virulizin R 63 SAR# [002] 63 AVE# 63 Phase Ib IIa 63 drug GAP #B# 63 Phase IIa trials 63 tremelimumab 63 Interferon alpha 63 L BLP# 63 atacicept 63 SUVN 63 EGS# 63 NOX E# 63 HGS# 63 rindopepimut 63 PrevOnco ™ 63 TMC# [002] 63 phase IIb 63 Prestara 63 BCR ABL inhibitor 63 Hematide TM 63 Maribavir 63 EndoTAG TM 63 motesanib 63 investigational therapies 63 Loramyc R 63 PANVAC VF 63 KNS # 63 Cloretazine 63 SRT# [003] 63 NTDDS 63 PNT# 63 HepeX B 63 budesonide foam 63 eprodisate Fibrillex TM 63 aleglitazar 63 Increlex R 63 VitiGam 63 nucleotide analog 63 Imvamune 63 TOCOSOL Camptothecin 63 eosinophilic asthma 63 Reverset 63 Sebivo 63 Phase #/#a trial 63 IAP inhibitors 63 Ixempra 63 THR beta agonist 63 TransMID 63 ATryn ® 63 Albugon 63 novel therapeutic antibodies 63 Quinamed 63 ZADAXIN ® 63 Triapine R 63 TroVax ® 63 PSN# [001] 63 CYT# potent vascular disrupting 63 oral prodrug 63 Campath alemtuzumab 63 Aptivus ® 63 DPX Survivac 63 PRT# 63 axitinib 63 BNC# 63 valopicitabine 63 inhaled AAT 63 Dacogen decitabine 63 Relovair 63 Vicinium TM 63 BENLYSTA ® 63 Betaferon ® 63 OMP #M# 63 briakinumab 63 Arimoclomol 63 solanezumab 63 dexanabinol 63 Dalbavancin 63 including eniluracil ADH 63 Certican 63 Cintredekin Besudotox 63 E1 INT TM 63 Romiplostim 63 Cinquil 63 Phase Ib 63 Amplimexon 63 Apaziquone 63 Desmoteplase 63 preclinically 63 PEG Interferon lambda 63 sJIA 63 MAXY VII 63 CytoFab 63 visilizumab 63 PGL# 63 registrational 63 DU #b 63 miglustat 63 neratinib 63 PROCHYMAL 63 Urocidin 63 Syncria 63 tarenflurbil 63 postoperative ileus 63 albiglutide 63 Uvidem 62 MBP# [001] 62 Lixivaptan 62 Phase III clinical trials 62 pitavastatin 62 Enzastaurin 62 rhIGF-I/rhIGFBP-3 62 subcutaneous PRO 62 Kahalalide F 62 zanolimumab 62 diabetic neuropathic pain 62 lixivaptan 62 enzastaurin 62 obatoclax 62 Flutiform TM 62 Evoltra ® 62 ATG Fresenius S 62 TLR9 agonist 62 tiapamil 62 intranasal formulation 62 AIMM trial 62 Spiegelmer 62 OncoVex 62 Neuvenge 62 Dasatinib 62 sitaxsentan 62 Nuvion 62 lomitapide 62 Gleevec imatinib mesylate 62 DPP4 62 Ophena 62 dalbavancin 62 class mGluR5 inhibitor 62 EndoTAGTM 1 62 ACZ# 62 TELINTRA 62 EDEMA3 62 MAXY alpha 62 ApoB SNALP 62 EOquin 62 Iluvien ® 62 GVAX ® 62 Pradefovir 62 PEG PAL 62 ATryn R 62 SUTENT ® 62 multiple myeloma MM 62 fostamatinib 62 TPI ASM8 62 ProSavin 62 alvimopan 62 Silodosin 62 Tavocept 62 IND submission 62 oral antiviral 62 Belimumab 62 ZEFTERA TM Zevtera TM 62 Orathecin 62 Omacetaxine 62 CRD5 62 regorafenib 62 oral PTH 62 MT#/MEDI-# 62 incyclinide 62 zileuton 62 LUX Lung 62 sodium glucose cotransporter 62 rufinamide 62 hereditary deficiency 62 Talabostat 62 JAK3 62 KIACTA ™ 62 cancer immunotherapies 62 drug ISA# 62 Somatuline Depot 62 Kinoid 62 INSPIRE Trial Phase III 62 OncoGel 62 Genentech Rituxan 62 tubulin inhibitor 62 Firazyr 62 omacetaxine mepesuccinate 62 Xanafide 62 brivaracetam 62 Androxal ® 62 PRX # 62 IMiDs ® 62 Heplisav 62 Telatinib 62 Fibrin Pad 62 Egrifta 62 lupus nephritis 62 Rezonic 62 Phase 1b clinical 62 OvaRex 62 Teriflunomide 62 TKM ApoB 62 histone deacetylase HDAC inhibitor 62 Myocet 62 pertuzumab 62 protein tyrosine phosphatase 1B 62 Hepatocellular Carcinoma HCC 62 ulimorelin 62 beta 1a 62 REBETOL combination therapy 62 GeoVax vaccine 62 vismodegib 62 Ozarelix 62 Tykerb lapatinib 62 NXL# 62 StemEx 62 mapatumumab 62 REMINYL ® 62 Factor VIIa 62 Revlimid lenalidomide 62 dose escalation Phase 62 adult chronic ITP 62 Prodarsan ® 62 Genasense ® oblimersen 62 Aplidin R 62 tafamidis 62 Anavex #-# 62 nitazoxanide 62 Increlex ® 62 JZP 62 ICA # 62 ANAVEX #-# [001] 62 Curaxin CBLC# 62 valtorcitabine 62 investigational protease inhibitor 62 LE DT 62 dirucotide 62 PSN# [002] 62 Genasense ® 62 null responder HCV 62 edifoligide 62 INS# [001] 62 trastuzumab DM1 62 HuMax CD# 62 Abiraterone acetate 62 luliconazole 62 ThermoDox R 62 PEG SN# 62 StaphVAX 62 Solazed 62 eniluracil 62 IV APAP 62 ancrod 62 virus HCV protease inhibitor 62 LHRH antagonist 62 ZK EPO 62 Gabapentin GR 62 AZILECT ® 62 ATPace TM 62 AZILECT R 62 phase IIb study 62 Gleevec imatinib 62 basal insulin analogue 62 Diamyd r vaccine 62 interferon gamma 1b 62 HCV protease inhibitors 62 Orazol 62 polysaccharide polymer 62 oncolytic vaccine 62 TYZEKA 62 custirsen 62 bortezomib Velcade 62 Microplasmin 62 Phase Ib clinical 62 SomatoKine 62 rALLy clinical trial 62 toenail onychomycosis 62 Atiprimod 62 GATTEX ® 62 Ilaris 62 Degarelix 62 docetaxel Taxotere R 62 MGd 62 Cx# [002] 62 Cardio Vascu Grow 62 DCVax Brain 62 ORMD 62 Nanobody R 62 Mycograb 62 Cimzia TM 62 TBC M4 62 amrubicin 62 urocortin 2 62 nucleoside analog 62 treatment naive genotype 62 P#X# antagonist 62 OMNARIS HFA 62 metastatic hormone refractory 62 CMV vaccine 62 thetreatment 62 Prodarsan R 62 oropharyngeal candidiasis 62 double blinded placebo 62 Pazopanib 62 relapsed leukemia 62 Fabry Disease 62 CYT# QbG# 62 investigational compounds 62 XmAb# 62 JAK3 inhibitor 62 HGS ETR2 62 oxaliplatin Eloxatin 62 LAF# 62 mitogen activated ERK kinase 62 mTOR kinase 62 Chrysalin 62 Unit Dose Budesonide 62 QNEXA 62 Nexavar ® 62 dexpramipexole 62 ImmunoGen TAP technology 62 TG MV 62 Onalta ™ 62 Zybrestat 62 PREOS 62 Ophena TM 62 Tocilizumab 62 Azilect ® 62 BrachySil TM 62 compound KOS 62 thalidomide Thalomid 62 pediatric acute lymphoblastic 62 samalizumab 62 histamine dihydrochloride 62 Vitaxin 62 HGS ETR1 62 dacetuzumab 62 Axitinib 62 farletuzumab 62 Afatinib 62 Phase 2b trial 62 PDX pralatrexate 62 Akt inhibitor 61 glufosfamide 61 Prednisporin TM 61 investigational humanized monoclonal antibody 61 DXL# 61 prucalopride 61 epothilones 61 phase IIb III 61 GED aPC 61 Vacc 4x 61 atrasentan 61 next generation URAT1 61 Epratuzumab 61 IAP inhibitor 61 Mycamine 61 Xelox 61 Liprotamase 61 pharmacokinetic PK study 61 CB2 selective receptor agonist 61 Zarnestra 61 Phase IIa clinical trials 61 tocilizumab 61 Sapacitabine 61 Nanobody ® 61 OMAPRO 61 clinical pharmacology studies 61 A3 adenosine receptor 61 Clavis Pharma 61 CCR5 mAb 61 Taxotere docetaxel 61 KRN# 61 ruxolitinib 61 chimeric monoclonal antibody 61 Motavizumab 61 Elocalcitol 61 Sprycel dasatinib 61 Peginterferon alfa 2b 61 Staphylococcus aureus Polysaccharide Conjugate 61 radiation sensitizer 61 Kepivance 61 Clolar ® 61 Naproxcinod 61 Qnexa TM 61 Phase III Clinical Trials 61 Dendreon Provenge 61 cediranib 61 advanced metastatic prostate 61 Teplizumab 61 rEV# 61 Phase #b/#a clinical 61 Angiocept 61 Noxafil 61 aurora kinase 61 R#/MEM 61 VitiGam TM 61 Japanese Encephalitis vaccine 61 BRAF V# mutation 61 systemically administered 61 ALS #-# 61 TOLAMBA 61 TKM PLK1 61 Gattex 61 non nucleoside inhibitor 61 inhibit metastasis 61 Enkephalin 61 telomerase therapeutic 61 CCR5 antagonist 61 bendamustine HCl 61 Elvitegravir 61 OMP #R# 61 dose escalation clinical 61 Nexavar sorafenib tablets 61 MyVax 61 Denufosol 61 cilengitide 61 Naglazyme 61 μg dose 61 orphan designation 61 Tocosol Paclitaxel 61 Vectibix panitumumab 61 Liprostin 61 Vaxfectin 61 AAG geldanamycin analog 61 apricitabine ATC 61 Cytolin ® 61 Annamycin 61 ORENCIA R 61 squalamine 61 corticosteroid dexamethasone 61 Synavive 61 CytoFabTM 61 Vimpat R 61 luteinizing hormone releasing 61 telaprevir VX 61 DCCR 61 Onalta 61 Clevudine 61 trodusquemine 61 apricitabine 61 CINTREDEKIN BESUDOTOX 61 VA# [002] 61 diarrhea predominant irritable 61 Janus kinase 61 QLT# 61 Acetavance TM intravenous acetaminophen 61 Cethrin R 61 RoACTEMRA 61 Preos 61 Maraviroc 61 Engerix B 61 seliciclib CYC# 61 AA amyloidosis 61 OncoVEX 61 USL# 61 blinatumomab 61 hepatitis C HCV 61 Yondelis ® 61 eltrombopag 61 ularitide 61 biliary tract cancer 61 heterozygous FH 61 ADAGIO study 61 Blinatumomab 61 Qutenza TM 61 Zelrix 61 ALN VSP 61 ISIS # 61 Orphan Drug status 61 PhG alpha 1 61 ILUVIEN ® 61 Davanat 61 Alinia 61 Sutent sunitinib 61 nitric oxide donating prostaglandin 61 LCP AtorFen 61 IMiDs R 61 cell lymphoma CTCL 61 LEUKINE 61 SPC# [001] 61 Cimzia ® certolizumab pegol 61 Twinrix 61 LY# [003] 61 investigational compound 61 receptor inhibitor 61 mGluR2 NAM 61 posaconazole 61 delivers fluocinolone acetonide FA 61 FTY# 61 pramlintide metreleptin combination 61 ToGA 61 Phase III Clinical Trial 61 BENLYSTA TM 61 ofatumumab HuMax CD# 61 Tyrima 61 MGCD# [001] 61 treatment naïve genotype 61 AFREZZA TM 61 Androxal TM 61 TG# [003] 61 dose escalation phase 61 decitabine 61 AGHD 61 cardio renal 61 IMC #B 61 non alcoholic steatohepatitis 61 oncolytic virus therapies 61 Ambrisentan 61 tesofensine 61 OX1 61 DCVax 61 ONCONASE 61 renin inhibitors 61 Cerashield 61 Omnitarg 61 afamelanotide 61 RNAi therapeutic targeting 61 EchoCRT 61 sodium glucose transporter 61 Tanespimycin 61 Virulizin 61 Junovan TM 61 Actilon 61 cutaneous T 61 Bicifadine 61 LymphoStat B TM 61 placebo controlled Phase III 61 AQ4N 61 HDL Selective Delipidation 61 Phase III randomized controlled 61 romidepsin novel 61 small molecule thrombopoietin 61 maximally tolerated dose 61 gastro intestinal inflammation 61 Serdolect ® 61 PRIMO CABG 61 rhMBL 61 DPP4 inhibitor 61 Tyzeka Sebivo 61 prostone 61 Eniluracil 61 NeuroVax 61 VGV 1 61 humanized interleukin 6 61 tosedostat 61 rheumatoid arthritis psoriatic arthritis 61 romidepsin 61 Lodotra 61 isoform selective 61 faropenem 61 Pfizer Sutent 61 MEK inhibitor RDEA# 61 recombinant subunit vaccine 61 metastatic bladder 61 ZACTIMA 61 efficacy endpoint 61 aflibercept VEGF Trap 61 cMET 61 Tolamba 61 Toctino R 61 multicenter Phase III 61 recombinant biopharmaceutical 61 confirmatory Phase III 61 deforolimus 61 acetonide FA 61 ALN VSP Phase 61 Zalbin 61 prGCD 61 Alferon N 61 omiganan 61 Elotuzumab 61 ganaxolone 61 gepirone ER 61 evaluating tivozanib 61 BiovaxID 61 MERREM 61 Advagraf 61 antiobesity 61 Proleukin 61 AGILECT R 61 Elisabeth Lindner CEO 61 MAGE A3 61 RANK Ligand inhibitor 61 lucinactant 61 Arzerra ofatumumab 61 oral picoplatin 61 Santhera 61 BAL# [002] 61 CONBRIZA 61 Zenvia ™ 61 SparVax TM 61 Atrasentan 61 cinacalcet 61 Anturol TM 61 #D#C# 61 GLP toxicology studies 61 IMC A# 61 BEXXAR 61 Cand5 61 AMEVIVE 61 Tesetaxel 61 immunotherapeutic approaches 61 Kevetrin 61 ChronVac C R 61 pafuramidine maleate 61 intranasal insulin product 61 tgAAC# 61 Phase III Pivotal 61 hematological malignancy 61 HuCAL antibodies 61 anticoagulant reversing agent 61 Orphan designation 61 sorafenib Nexavar 61 CINQUIL 61 Interferon beta 61 Itopride 61 trastuzumab emtansine T DM1 61 ganetespib 61 Phase IIb clinical 61 omega interferon 61 vaginally administered lidocaine 61 personalized immunotherapy 61 Panitumumab 61 pivotal bioequivalence 61 apremilast 61 Cannabinor 61 ataluren 61 Surfaxin LS 61 oral FTY# 61 Syncria albiglutide 61 Stimuvax R 61 humanised antibody 61 Nicole Onetto MD 61 cetrorelix pamoate 61 TREANDA 61 lasofoxifene 61 orally dosed 61 Vicriviroc 61 hoFH 61 TYGACIL 61 Herceptin trastuzumab 61 JAK2 inhibitor 61 EVIZON TM squalamine lactate 61 fusion inhibitor 61 EnzymeRx 61 BIM #A# 61 MyVax R 61 MNTX 60 Stelara 60 pan HDAC inhibitor 60 Granulocyte Colony Stimulating Factor 60 Empatic TM 60 Dyloject TM 60 oral salmon calcitonin 60 Telintra